NCT07599423 A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Large B-Cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07582315 A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01) Status NOT_YET_RECRUITING Phase PHASE3
NCT07580339 Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07570914 Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases Status NOT_YET_RECRUITING Phase PHASE2
NCT07570823 A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE3
NCT07561060 Low Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Concurrent Tislelizumab Immunotherapy Status RECRUITING Phase PHASE1/PHASE2
NCT07554521 A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States Status RECRUITING Phase PHASE2
NCT07554482 Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07551479 SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07549906 Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study Status NOT_YET_RECRUITING Phase PHASE2
NCT07532902 A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer Status RECRUITING Phase PHASE1
NCT07529613 Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT07515625 Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07503756 JS212 Combination Therapies in Metastatic Colorectal Cancer Status RECRUITING Phase PHASE2
NCT07490301 A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT07490262 A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment. Status RECRUITING Phase PHASE2/PHASE3
NCT07480850 Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07477743 A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07474727 A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer Status NOT_YET_RECRUITING Phase PHASE2